BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7386289)

  • 1. Improved anticancer effect by combining cytotoxic drugs with an inhibitor of prostaglandin synthesis.
    Berstock DA; Houghton J; Bennett A
    Adv Prostaglandin Thromboxane Res; 1980; 6():567-9. PubMed ID: 7386289
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy.
    Bennett A; Berstock DA; Carroll MA
    Br J Cancer; 1982 May; 45(5):762-8. PubMed ID: 7082558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction by flurbiprofen of primary tumor growth and local metastasis formation in mice.
    Leaper DJ; French B; Bennett A
    Adv Prostaglandin Thromboxane Res; 1980; 6():591-3. PubMed ID: 7386295
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer growth, response to treatment and survival time in mice: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen.
    Bennett A; Houghton J; Leaper DJ; Stamford IF
    Prostaglandins; 1979 Feb; 17(2):179-91. PubMed ID: 441430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer and prostaglandins: a new approach to treatment.
    Leaper DJ; French BT; Bennett A
    Br J Surg; 1979 Oct; 66(10):683-6. PubMed ID: 509040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved anticancer effect by combining cytotoxic drugs with an inhibitor of prostaglandin synthesis.
    Berstock DA; Houghton J; Bennett A
    Cancer Treat Rev; 1979 Jun; 6 Suppl():69-71. PubMed ID: 115588
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kinetics of the cell proliferation of murine mammary adenocarcinoma under the influence of methylcobalamine].
    Golenko OD; Arsenian FG; Miasishcheva NV; Sof'ina ZP
    Biull Eksp Biol Med; 1980 Feb; 89(2):185-7. PubMed ID: 7370419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of methylcobalamin on methotrexate transport in normal and tumorous tissues].
    Miasishcheva NV; Gerasimova GK; Il'ina NS; Sof'ina ZP
    Biull Eksp Biol Med; 1985 Jun; 99(6):736-8. PubMed ID: 4016268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flurbiprofen--a new anti-prostaglandin anti-inflammatory drug in rheumatoid arthritis.
    Gulati PD; Sharma RK; Sood KC; Rizvi SN
    J Assoc Physicians India; 1981 Aug; 29(8):603-7. PubMed ID: 7040332
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biosynthesis of cobalamin coenzymes in tumor and hematopoietic tissues in assessing methotrexate sensitivity].
    Miasishcheva NV; Vares IuV; Golenko OD; Nikolaeva TG
    Vestn Akad Med Nauk SSSR; 1986; (5):36-41. PubMed ID: 3727783
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitumor activity in a rat mammary adenocarcinoma: the effect of cyclooxygenase inhibitors and immunization against prostaglandin E2.
    Karmali RA; Marsh J
    Prostaglandins Leukot Med; 1985 Dec; 20(3):283-6. PubMed ID: 3937158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of antibody and macrophages in spontaneous and drug-induced regression of the T1699 mammary adenocarcinoma.
    Haskill JS; Key M; Radov LA; Parthenais E; Korn JH; Fett JW; Yamamura Y; DeLustro F; Vesley J; Gant G
    J Reticuloendothel Soc; 1979 Oct; 26(4):417-25. PubMed ID: 316009
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of the initial chemotherapy on subsequent therapy.
    Simpson-Herren L; Noker PE
    Prog Clin Biol Res; 1990; 354A():21-9. PubMed ID: 2247488
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental study on the establishment of a mammary adenocarcinoma MA--737 (author's transl)].
    Sun WY; Ma KS; Guan JF
    Zhonghua Zhong Liu Za Zhi; 1980 Sep; 2(3):168-73. PubMed ID: 7227180
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of combined glycolytic inhibitor, respiratory inhibitor, and protein antagonist on experimental tumor growth.
    Silverstein MN; Linman JW
    Mayo Clin Proc; 1967 Jun; 42(6):313-7. PubMed ID: 6025632
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of mammary carcinogenesis by flurbiprofen, a non-steroidal antiinflammatory agent.
    McCormick DL; Moon RC
    Br J Cancer; 1983 Dec; 48(6):859-61. PubMed ID: 6652027
    [No Abstract]   [Full Text] [Related]  

  • 17. Host immune potentiation of drug responses to a murine mammary adenocarcinoma. II. Effect of melphalan therapy on the host immune system.
    Radov LA; Korn JH; Haskill JS
    Int J Cancer; 1976 Nov; 18(5):630-8. PubMed ID: 992900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour growth and response to treatment: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen [proceedings].
    Bennett A; Houghton J; Leaper DJ; Stamford IF
    Br J Pharmacol; 1978 Jun; 63(2):356P-357P. PubMed ID: 667439
    [No Abstract]   [Full Text] [Related]  

  • 19. Indomethacin or flurbiprofen treatment of periodontitis in beagles: effect on crevicular fluid arachidonic acid metabolites compared with effect on alveolar bone loss.
    Williams RC; Offenbacher S; Jeffcoat MK; Howell TH; Johnson HG; Hall CM; Wechter WJ; Goldhaber P
    J Periodontal Res; 1988 Mar; 23(2):134-8. PubMed ID: 2967365
    [No Abstract]   [Full Text] [Related]  

  • 20. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
    Sirotnak FM; Otter GM; Schmid FA
    Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.